ICD-10-CM Billable Code

T38.1X6

Underdosing of thyroid hormones and substitutes

Clinical Classification Guidelines

Medical Intelligence & Overview

Underdosing of thyroid hormones and substitutes occurs when a person receives a lower dose of medication than what is medically prescribed for managing thyroid-related conditions. Proper medication dosing is crucial for maintaining the balance of thyroid hormones, which are vital for regulating metabolism, energy levels, and overall bodily functions. When doses are insufficient, symptoms of hypothyroidism may emerge or worsen, impacting quality of life. This condition is classified under ICD-10 code T38.1X6 and requires careful management to ensure appropriate hormone levels and prevent complications.

Causes & Symptoms

Clinical Causes: Patient non-adherence to prescribed medication regimen Physician errors in prescribing the correct dosage Medication absorption issues due to gastrointestinal problems Drug interactions that reduce the effectiveness of thyroid hormone absorption Inadequate monitoring leading to reduced dosage adjustments over time Supply issues causing interruption or reduction of medication availability Attempts to minimize side effects leading to intentional underdosing

Key Symptoms: Fatigue and weakness Weight gain Cold intolerance Constipation Dry skin and hair Depressive mood or low mood Memory difficulties and impaired concentration Muscle aches and stiffness Swelling, especially around the face and extremities

Diagnostic & Treatment

Diagnosis Path: Diagnosing underdosing involves a combination of clinical assessment and laboratory tests. Healthcare providers typically measure levels of thyroid-stimulating hormone (TSH) and free thyroid hormones (free T4 and T3). Elevated TSH levels alongside low or normal thyroid hormone levels suggest insufficient medication dosing. A thorough review of medication history, adherence, and possible absorption issues is also essential for accurate diagnosis.

Treatment Protocols: Treatment focuses on correcting the underdosing by adjusting the medication dosage prescribed for the individual. Once the appropriate dose is identified, healthcare providers may recommend regular monitoring through blood tests to ensure hormone levels remain within the desired range. Education on consistent medication intake, awareness of potential drug interactions, and addressing any absorption problems are vital components of management. In some cases, switching to alternative formulations or methods of delivery may be necessary to improve efficacy.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T38.1X6 a billable ICD-10 code?
Yes, T38.1X6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T38.1X6?
Clinical documentation must specify the nature of Underdosing of thyroid hormones and substitutes and any associated comorbidities for accurate reporting.

Cite this Clinical Reference